Fig. 7From: In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic feverSuperimposition of vaccine complexes through MD simulation. A TLR3-V2, B TLR8-V2, and C TLR4-V1Back to article page